Pradžia › Šlapimo pūslės vėžys › Washington › Seattle
Šlapimo pūslės vėžys klinikiniai tyrimai Seattle, WA
Vienas tyrimas dėl Šlapimo pūslės vėžys ieško dalyvių vietoje Seattle arba jos apylinkėse. Atidarykite jį, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- ir dar 1
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Renkami dalyviai2 fazė
- University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Renkami dalyviai2 fazė
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- University of Washington Medical Center - Montlake, Seattle
Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer
Renkami dalyviai1/2 fazė
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Renkami dalyviai1/2 fazė
- Eye Associates Northwest - Ballard Clinic and Surgery Center, Seattle
- Eye Associates Northwest - First Hill Clinic, Seattle
- Harborview Medical Center, Seattle
- ir dar 3
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Renkami dalyviai1 fazė
- Swedish Cancer Institute, Seattle
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Renkami dalyviai3 fazė
- Fred Hutchinson Cancer Research Center ( Site 0787), Seattle
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Renkami dalyviai1/2 fazė
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Renkami dalyviai
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
Renkami dalyviai1/2 fazė
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Renkami dalyviaiStebimasis tyrimas
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Renkami dalyviai2/3 fazė
- Local Institution - 0200, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Renkami dalyviai2 fazė
- University of Washington School of Medicine, Seattle
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Renkami dalyviai3 fazė
- Research Site, Seattle
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Renkami dalyviai2 fazė
- Harborview Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
Renkami dalyviai
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Renkami dalyviai1 fazė
- Swedish Cancer Institute, Seattle
- Swedish Medical Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Renkami dalyviai1 fazė
- Fred Hutchinson Cancer Center, Seattle
Blue Light Cystoscopy With Cysview® Registry
Renkami dalyviaiStebimasis tyrimas
- University of Washington Medicine, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Renkami dalyviaiStebimasis tyrimas
- Massive Bio SYNERGY-AI site, Seattle
Šlapimo pūslės vėžys tyrimai kituose miestuose
- New York City, NY35 tyrimai
- Nashville, TN31 tyrimas
- Houston, TX31 tyrimas
- Dallas, TX27 tyrimai
- Boston, MA26 tyrimai
- Washington, DC26 tyrimai
- Los Angeles, CA24 tyrimai
- Baltimore, MD24 tyrimai
- St. Louis, MO22 tyrimai
- Philadelphia, PA21 tyrimas
- Edison, NJ21 tyrimas
- Chicago, IL21 tyrimas
Kiti tyrimai Seattle
- Nedidelinių ląstelių plaučių vėžys53 tyrimai
- Vėžys (visų tipų)49 tyrimai
- Prostatos vėžys42 tyrimai
- Ūmi mieloidinė leukemija40 tyrimai
- Krūties vėžys39 tyrimai
- Metastatinis vėžys39 tyrimai
- Storosios ir tiesiosios žarnos vėžys34 tyrimai
- Plaučių vėžys33 tyrimai
- Kiaušidžių vėžys30 tyrimai
- Kartotinė mieloma22 tyrimai
- Mielodisplastiniai sindromai21 tyrimas
- Ūmi limfoblastinė leukemija21 tyrimas
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.